Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rajib Lochan Bezbaruah is active.

Publication


Featured researches published by Rajib Lochan Bezbaruah.


Bioinformation | 2014

Virtual Screening of compounds from Tabernaemontana divaricata for potential anti-bacterial activity.

Rashmi Rekha Gogoi; Dhrubajyoti Gogoi; Rajib Lochan Bezbaruah

Virtual Screening and Molecular Docking analysis for Tabernaemontana divaricata derived 66 Law Molecular Weight Compounds (LMW) was conducted and to identified and predicted novel molecules as a inhibitor of Streptococcus pneumonia. The investigation has revealed several compounds with optimum binding towards Penicillin-binding proteins, Sialidases, Aspartate betasemialdehide dehydrogenase cell membrane protein of Streptococcus pneumonia. Docking results were computed in term of binding energy, ligand efficiency and number of hydrogen bonding. Apparicine (-5.14), 5-Hydroxyvoaphylline (-4.78), Voacangine (-4.7), 19-Hydroxycoronaridine (-4.44) and Coronaridine (-4.72) are identified as most suitable to bind with N-acetylglucosamine-1- phosphate uridyltransferase receptor. Ervaticine (-6.33), Ibogamine (-6.15), Methylvoaphylline (-5.74) and Coronaridine hydroxyindolenine (-5.32) has showed novel binding against the penicillin-binding proteins. Ervaticine (-6.42), 5-oxo-11-hydroxy voaphylline (-6.18), Conolobine B (-6.02) has found optimum binding against the active site of NanB sialidase of Streptococcus pneumonia. The compounds 3S-Cyanocoronaridine (-6.71), 19-Epivoacristine (-5.48) and Ervaticine(-5.45) interacting with aspartate beta-semialdehide and found suitable with least docking score.


Bioinformation | 2014

Design of inhibitors of the HIV-1 integrase core domain using virtual screening.

Preetom Regon; Dhrubajyoti Gogoi; Ashok Kumar Rai; Manabjyoti Bordoloi; Rajib Lochan Bezbaruah

Acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV). The integrase (IN) enzyme of HIV interacts with several cellular and viral proteins during the integration process. Thus, it represents an appropriate target for antiretroviral drugs (ARVs). We performed virtual screening of database compounds and designed analogues using Elvitegravir (EVG) as a standard compound. The 378 screened compounds were retrieved from ZINC, ChemSpider, PubChem, and ChemBank Chemical Databases based on chemical similarity and literature searches related to the structure of EVG. The Physiochemical properties, Bioactivity, Toxicity and Absorption, Distribution, Metabolism and Excretion of Molecules (ADME) of these compounds were predicted and docking Experiments were conducted using Molegro Virtual Docker software. The docking and ADME suggested very significant results in regard to EVG. The MolDock and Rerank scores were used to analyze the results. The compounds ZINC26507991 (-84.22), Analogue 9 (-68.49), ZINC20731658 (-66.79), ZINC00210363 (-43.44) showed better binding orientation with IN receptor model with respect to EVG (182.52). The ZINC26507991 has showed significant ADME result.


Indian Journal of Microbiology | 2012

Molecular Interaction of Novel Compound 2-Methylheptyl Isonicotinate Produced by Streptomyces sp. 201 with Dihydrodipicolinate Synthase (DHDPS) Enzyme of Mycobacterium tuberculosis for its Antibacterial Activity

Salam Pradeep Singh; Tarun C. Bora; Rajib Lochan Bezbaruah

Antibiotic resistance is a growing problem in multi-drug-resistant tuberculosis which is caused by Mycobacterium tuberculosis (MTB). Hence there is an urgent need for designing or developing a novel or potent anti-tubercular agent. The Lysine/DAP biosynthetic pathway is a promising target because of its role in cell wall and amino acid biosynthesis. In our study we performed a molecular docking analysis of a novel antibacterial isolated from Streptomyces sp. 201 at three different binding site of dihydrodipicolinate synthase (DHDPS) enzyme of MTB. The molecular docking studies suggest that the novel molecule shows favourable interaction at the three different binding sites as compared to five experimentally known inhibitors of DHDPS.


Bioinformation | 2012

Prediction of the three-dimensional structure of serine/threonine protein kinase pto of Solanum lycopersicum by homology modelling.

Salam Pradeep Singh; Sarangthem Vivek; Rajib Lochan Bezbaruah; Madhumita Barooah

The resistant gene Pto of Solanum lycopersicum interacts with the avr Pto gene product of the bacterial pathogen Pseudomonas syringae pv tomato to launch a cascade of molecular events that triggers the hypersensitive disease-resistance response in tamato. The paper describes attempts to predict the structure of Pto encoding a serine/threonine protein kinase to understand the mechanism and function. A three-dimensional model based on the crystal structure of effect protein Avr ptob complexed with Kinase Pto and bacterial effector protein Avrpto was generated using Modeller9v7. We adopted different modelling approaches for our study, Intialy, we generated a model based on a single template protein and then a model based on multiple templates. The models generated through these approaches were further assessed with ANOLEA energy assessment, Ram Page server and PROCHECK for stereochemistry and geometry check. Comparative analysis suggested that the model generated was better than the templates. This study paves the way for generating computer molecular models for proteins whose crystal structures are not available and which would aid in studying protein-protein interactions.


Medicinal Chemistry Research | 2013

Molecular docking and in silico studies on analogues of 2-methylheptyl isonicotinate with DHDPS enzyme of Mycobacterium tuberculosis

Salam Pradeep Singh; Bolin Kumar Konwar; Rajib Lochan Bezbaruah; Tarun C. Bora

Mycobacterium tuberculosis and other strains of mycobacteria cause tuberculosis which has infected one-third of the world’s population. Moreover, there has been increase in multidrug-resistant strains which spotlights the need for a new anti-tuberculosis drug. The cell wall of mycobacteria is characterised by high diaminopimelic acid (DAP) content—an intermediate of the (S)-lysine biosynthetic pathway and dihydrodipicolinate synthase (DHDPS) enzyme catalyses the first unique reaction of this biosynthesis. Interestingly, the gene knockout experiment demonstrates the essentiality of the DAP pathway, where the absence of DAP results in cell lysis and death. Because of this importance, any inhibitor of DHDPS enzyme may indicate a new class of anti-tubercular agent. In this perspective, the aim of the present study is to focus on the molecular docking analysis of DHDPS enzyme against the analogues of 2-methylheptyl isonicotinate—a compound having strong antibacterial property against Mycobacterium tuberculosis. The analogues used in the present study were retrieved from the NCBI PubChem database subject to Lipinski rule of five filters which would make the analogues like an orally active drug. Further, the top docked compounds at the active site of the DHDPS enzyme were analysed for ADME-Toxicity prediction.


Bioinformation | 2012

Insights from the docking analysis of biologically active compounds from plant Litsea Genus as potential COX-2 inhibitors.

Dhrubajyoti Gogoi; Rajib Lochan Bezbaruah; Manabjyoti Bordoloi; Rajeev Sarmah; Tarun C. Bora


Drug Invention Today | 2013

Virtual screening on potential neuraminidase inhibitors of influenza A virus H1N1

Salam Pradeep Singh; Dhrubajyoti Gogoi; Rajib Lochan Bezbaruah; Manab Jyoti Bordoloi; Nabin C. Barua


Journal of Biophysical Chemistry | 2012

Insilico studies of 2-methylheptyl isonicotinate produced by Streptomyces sps. 201 against dihydrodipicolinate synthase enzyme of Mycobacterium tuberculosis

Salam Pradeep Singh; Rajib Lochan Bezbaruah; Tarun C. Bora


Archive | 2014

3D- Comparative Modelling, Structure Comparison & Docking Studies for AVPR2 Protein with Some Anti-Diabetic Plant Compounds from North East India

Robin Das; Dhrubajyoti Gogoi; Soyonlal Bhoumick; Surovi Saikia; Rajib Lochan Bezbaruah; Tarun C. Bora; Kishore Sarma; Mousumi Sahu; Madhumita Barooah


Archive | 2014

tuberculosis using ligand based drug design approach using ligand based drug design approach using ligand based drug design approach using ligand based drug design approach

Bhaskor Kolita; Dhrubajyoti Gogoi; Partha P. Dutta; Manobjyoti Bordoloi; Rajib Lochan Bezbaruah

Collaboration


Dive into the Rajib Lochan Bezbaruah's collaboration.

Top Co-Authors

Avatar

Dhrubajyoti Gogoi

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tarun C. Bora

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Madhumita Barooah

Assam Agricultural University

View shared research outputs
Top Co-Authors

Avatar

Manobjyoti Bordoloi

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Partha P. Dutta

North East Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kishore Sarma

Assam Agricultural University

View shared research outputs
Top Co-Authors

Avatar

Manab Jyoti Bordoloi

North East Institute of Science and Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge